Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

@article{Pickles2014PrognosticVO,
  title={Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators},
  author={Martin D. Pickles and Martin Lowry and David John Manton and Lindsay W. Turnbull},
  journal={European Radiology},
  year={2014},
  volume={25},
  pages={1097-1106}
}
To determine associations between dynamic contrast-enhanced MR imaging (DCE-MRI) parameters and survival intervals in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy (NAC), surgery, and adjuvant therapies. Further, to compare the prognostic value of DCE-MRI parameters against traditional survival indicators. DCE-MRI and MR tumour volume measures were obtained prior to treatment and post 2nd NAC cycle. To demonstrate which parameters were associated with… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Current approaches for neoadjuvant chemotherapy in breast cancer.

  • European journal of pharmacology
  • 2013
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

GroomAC,MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites

AF Chambers
  • Nat Rev Cancer 2:563–572
  • 2015
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…